Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2008 2
2011 1
2012 7
2013 2
2014 5
2015 5
2016 5
2017 10
2018 11
2019 6
2020 13
2021 15
2022 12
2023 16
2024 4
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Similar articles for PMID: 31644126

95 results

Results by year

Filters applied: . Clear all
Page 1
Safinamide.
[No authors listed] [No authors listed] 2019 Apr 8. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. 2019 Apr 8. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. PMID: 31644126 Free Books & Documents. Review.
Rasagiline.
[No authors listed] [No authors listed] 2017 Jul 21. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. 2017 Jul 21. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. PMID: 31643254 Free Books & Documents. Review.
The XINDI Study: A Randomized Phase III Clinical Trial Evaluating the Efficacy and Safety of Safinamide as Add-On Therapy to Levodopa in Chinese Patients with Parkinson's Disease with Motor Fluctuations.
Wei Q, Tan Y, Xu P, Tao E, Lu Z, Pan X, Wang B, Liu C, Dong X, Tian Y, Sun X, Cattaneo C, Chen S, Shang H; XINDI Study Investigators Group. Wei Q, et al. CNS Drugs. 2022 Nov;36(11):1217-1227. doi: 10.1007/s40263-022-00958-6. Epub 2022 Nov 8. CNS Drugs. 2022. PMID: 36346534 Free PMC article. Clinical Trial.
Effectiveness and safety of safinamide in routine clinical practice in a Belgian Parkinson's disease population: an open-label, levodopa add-on study.
Belgian Safinamide Study Group; Bergmans B, Bourgeois P, Cras P, Dethy S, De Klippel N, Franco G, Garraux G, Geens K, Jacquerye P, Jeanjean A, Supiot F, Van der Linden C, Krygier C. Belgian Safinamide Study Group, et al. Acta Neurol Belg. 2023 Jun;123(3):939-947. doi: 10.1007/s13760-022-02100-1. Epub 2022 Oct 6. Acta Neurol Belg. 2023. PMID: 36201116 Free PMC article.
95 results